Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](CymaBay Therapeutics, Inc.)"
Count: 23
Selected: 0
| NCT ID | Title |
|---|
| NCT06060665 | IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) | ||
| NCT06051617 | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | ||
| NCT04950764 | An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) | ||
| NCT04620733 | RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) | ||
| NCT04467684 | Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406 | ||
| NCT04024813 | A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC | ||
| NCT03602560 | ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) | ||
| NCT03551522 | A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) | ||
| NCT03369002 | Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects | ||
| NCT03301506 | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) | ||
| NCT02955602 | Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) | ||
| NCT02609048 | Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC) | ||
| NCT02472535 | Study to Evaluate the Effects of MBX-8025 in Patients With HoFH | ||
| NCT02252835 | Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout | ||
| NCT02063997 | Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients | ||
| NCT01416402 | Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients | ||
| NCT01399008 | Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients | ||
| NCT01336686 | Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout | ||
| NCT01035879 | Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes | ||
| NCT00814372 | Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin | ||
| NCT00701883 | Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol | ||
| NCT00422487 | Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes | ||
| NCT00353587 | Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin |
